LOGIN  |  REGISTER
Recursion
Terns Pharmaceuticals

Health Catalyst Recognized in Five Gartner® Hype Cycle™ Reports

September 05, 2023 | Last Trade: US$6.60 0.34 -4.90

SALT LAKE CITY , Sept. 5, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Health Catalyst was recognized in the latest Gartner Hype Cycle for Healthcare Providers, 2023 (July 2023); Hype Cycle for Healthcare Data, Analytics and AI, 2023 (July 2023); Hype Cycle for Digital Care Delivery Including Virtual Care, 2023 (July 2023); Hype Cycle for Real-Time Health System Technologies, 2023 (July 2023) and Hype Cycle for U.S. Healthcare Payers, 2023 (July 2023).

Gartner Hype Cycle annual reports provide an objective overview of the pitfalls and opportunities of the latest innovations in healthcare, among other sectors, so that industry leaders can make informed purchasing decisions and take action.

"We're encouraged to be included in five Gartner Hype Cycle reports for 2023," said Dan Burton, CEO of Health Catalyst. "We believe, as healthcare leaders continue to confront challenges, seen and unforeseen, they need data and analytics solutions that can deliver the outcomes they need to improve patient care, advance operational effectiveness, and achieve financial sustainability. We develop our solutions with this goal in mind and are grateful to receive this recognition from Gartner."

Specifically, Gartner recognized Health Catalyst in Advanced Analytics Architecture for Providers, Population Health Management Solutions, and Care Pathway Organization categories in the 2023 Hype Cycle for Healthcare Providers. Intended to identify and analyze technologies that benefit healthcare providers, Gartner states that "this Hype Cycle tracks the benefits and maturity levels of digital innovations, market solutions, and approaches for healthcare providers. It helps CIOs communicate with stakeholders on the future direction of IT and supports decision making to identify, understand and prioritize investments."

The 2023 Hype Cycle Healthcare Data, Analytics, and AI report also recognized Health Catalyst as a Sample Vendor. According to Gartner, "this Hype Cycle tracks the emerging technologies that will have the greatest impact on data, analytics, and AI initiatives in the payer, provider and life science sectors."

In addition to the above reports, Health Catalyst earned three additional mentions. The company was recognized in the 2023 Gartner Hype Cycle report for Real-Time Health System Technologies for its Health Information Exchange. According to Gartner, "This Hype Cycle includes technologies pivotal to the real-time health system vision. It is an essential reference for CIOs when assessing the value and impact of technologies that digitally transform the healthcare organization into a responsive, collaborative, smart, next-generation health system."

Health Catalyst's Care Pathway Orchestration was recognized in the Gartner Hype Cycle for Digital Care Delivery Including Virtual Care. According to Gartner, "This Hype Cycle identifies and tracks digital innovations and market solutions for optimizing and transforming the way in which healthcare providers deliver clinical care."

Health Catalyst's Population Health Management Solutions were also recognized in the 2023 Hype Cycle for U.S. Healthcare Payers. According to Gartner, "This Hype Cycle provides critical input for strategic planning by tracking the maturity level and adoption rate of payer technologies and deployment approaches."

Gartner Disclaimer

GARTNER and HYPE CYCLE are registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Gartner

Gartner delivers actionable, objective insight to executives and their teams. Its expert guidance and tools enable faster, smarter decisions and stronger performance on an organization's mission-critical priorities.

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Media Contact

Amanda Hundt

This email address is being protected from spambots. You need JavaScript enabled to view it.

575.491.0974

Stock Quote

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB